Igor Splawski
29Patents
7h-index
34Co-inventors
69Inventor score
Filing activity: Aug 17, 1998 → Sep 13, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8241628B2 | Compositions and methods for antibodies targeting complement protein C5 | Chemistry; Metallurgy | 54 | Active |
| US8883158B2 | Compositions and methods for antibodies targeting complement protein C5 | Chemistry; Metallurgy | 30 | Active |
| US6274332A | Mutations in the KCNE1 gene encoding human minK which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene | Emerging Cross-Sectional Technologies | 11 | Expired |
| US9051365B2 | Antibodies that bind factor P | Chemistry; Metallurgy | 11 | Active |
| US6207383A | Mutations in and genomic structure of HERG--a long QT syndrome gene | Chemistry; Metallurgy | 9 | Expired |
| US6277978A | KVLQT1--a long QT syndrome gene | Chemistry; Metallurgy | 9 | Expired |
| US6787309B2 | Alterations in the long QT syndrome genes KVLQT1 and SCN5A and methods for detecting same | Chemistry; Metallurgy | 8 | Expired |
| US6432644B1 | Mutations in the KCNE1 gene encoding human mink which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene | Emerging Cross-Sectional Technologies | 7 | Expired |
| US6323026A | Mutations in the KCNE1 gene encoding human mink which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene | Emerging Cross-Sectional Technologies | 6 | Expired |
| US9512222B2 | Lectin-like oxidized LDL receptor 1 antibodies and methods of use | Chemistry; Metallurgy | 6 | Active |
| US10106605B2 | Compositions and methods for antibodies targeting Epo | Chemistry; Metallurgy | 5 | Active |
| US6582913B1 | Diagnostic method for KVLQT1—a long QT syndrome gene | Chemistry; Metallurgy | 4 | Expired |
| US6150104A | Homozygous mutation in KVLQT1 which causes Jervell and Lange Nielsen syndrome | Chemistry; Metallurgy | 4 | Expired |
| US7208273B2 | Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmia | Chemistry; Metallurgy | 4 | Expired |
| US9365646B2 | Compositions and methods for antibodies targeting EPO | Chemistry; Metallurgy | 3 | Active |
| US6420124B1 | KVLQT1—a long qt syndrome gene | Chemistry; Metallurgy | 3 | Expired |
| US6451534B1 | KVLQT1—a long QT syndrome gene | Chemistry; Metallurgy | 3 | Expired |
| US6342357B1 | Alterations in the long QT syndrome genes KVLQT1 and SCN5A and methods for detecting same | Chemistry; Metallurgy | 2 | Expired |
| US9982046B2 | Methods of treating cardiovascular disorders with lectin-like oxidized LDL receptor 1 antibodies | Chemistry; Metallurgy | 2 | Active |
| US6864364B1 | MinK-related genes, formation of potassium channels and association with cardiac arrhythmia | Human Necessities | 1 | Expired |
| US9988440B2 | Compositions comprising antibodies targeting factor P | Chemistry; Metallurgy | 1 | Active |
| US10385127B2 | Compositions and methods for antibodies targeting EPO | Chemistry; Metallurgy | 1 | Active |
| US7247436B2 | Mutations in the KCNE1 gene encoding human minK which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene | Emerging Cross-Sectional Technologies | 0 | Expired |
| US7297489B2 | Mutations in and genomic structure of HERG—a long QT syndrome gene | Chemistry; Metallurgy | 0 | Expired |
| US10865237B2 | Nucleic acids encoding anti-Factor P antibodies | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.